CD274 and neoplasm: Based on the histologic and genetic resemblance of pulmonary LELC to NPC (4, 5, 11), one might naturally surmise that PD-1/PD-L1 inhibitors would emerge as another promising weapon in the therapeutic arsenal against this rare tumor.